Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Terminated 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 10Other hematologic neoplasm 7Other 4Myeloid 3

Conditions

Mucositis 17Pain 12Opioid-Induced Constipation 12Constipation 12Obesity 11Sexual Dysfunction, Physiological 9Head and Neck Neoplasms 8Neoplasms 7Breast Neoplasms 7Polycystic Ovary Syndrome 4Bronchiolitis Obliterans Syndrome 4Weight Loss 3Prostatic Neoplasms 3Intestinal Diseases 3Stomatitis 2Squamous Cell Carcinoma of Head and Neck 2Sexuality 2Prediabetic State 2Intestinal Obstruction 2Hyperinsulinism 2Fatigue 2Dyspnea 2Xerostomia 1Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Incontinence 1Tongue Neoplasms 1Testicular Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Bronchiolitis Obliterans Syndrome × Other × Clear all
NCT01696643 2018-11-15

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3 Terminated
1,407 enrolled 15 charts
Other

Opioid-Induced Constipation, Bronchiolitis Obliterans Syndrome, Constipation, Pain

NCT01901302 2018-11-15

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3 Terminated
61 enrolled 4 charts
Other

Opioid-Induced Constipation, Bronchiolitis Obliterans Syndrome, Constipation, Pain

NCT01901328 2018-11-15

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3 Terminated
49 enrolled 4 charts
Other

Opioid-Induced Constipation, Bronchiolitis Obliterans Syndrome, Constipation, Pain

NCT01901341 2018-11-15

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3 Terminated
44 enrolled 6 charts
Other

Opioid-Induced Constipation, Bronchiolitis Obliterans Syndrome, Constipation, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡